Jean-François Emile Selected Research

Non-Langerhans-Cell Histiocytosis (Histiocytosis, Non Langerhans Cell)

1/2018	Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease.
1/2017	High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-François Emile Research Topics

Disease

52	Neoplasms (Cancer) 11/2022 - 06/2002
15	Erdheim-Chester Disease 11/2020 - 02/2013
12	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2006
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 03/2016
11	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 12/2020 - 02/2013
11	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2017 - 08/2004
9	Colonic Neoplasms (Colon Cancer) 02/2022 - 05/2006
8	Histiocytosis 01/2021 - 09/2012
7	Neoplasm Metastasis (Metastasis) 01/2019 - 05/2003
6	Melanoma (Melanoma, Malignant) 01/2017 - 12/2012
5	Microsatellite Instability 01/2022 - 12/2011
5	Adenocarcinoma 01/2019 - 04/2011
4	Infections 01/2020 - 07/2003
3	Sarcoma (Soft Tissue Sarcoma) 01/2016 - 11/2009
3	Tuberculosis (Tuberculoses) 11/2008 - 02/2007
3	Hepatocellular Carcinoma (Hepatoma) 08/2003 - 10/2002
2	Lymphatic Metastasis 02/2022 - 11/2021
2	Histiocytic Sarcoma 01/2022 - 10/2014
2	Disease Progression 12/2020 - 01/2019
2	Chromosomal Instability (Chromosome Stability) 01/2020 - 05/2003
2	Virus Diseases (Viral Diseases) 01/2020 - 08/2006
2	Non-Langerhans-Cell Histiocytosis (Histiocytosis, Non Langerhans Cell) 01/2018 - 01/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2011 - 11/2009
1	Lung Neoplasms (Lung Cancer) 11/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2022
1	Lymphoma (Lymphomas) 01/2022
1	Extranodal Extension 11/2021
1	Gastritis 11/2020
1	Adenocarcinoma of Lung 01/2020
1	Pneumothorax 01/2020
1	Lung Diseases (Lung Disease) 01/2020

Drug/Important Bio-Agent (IBA)

12	VemurafenibIBA 11/2019 - 09/2012
10	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 08/2004
9	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
9	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2011
8	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2008
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 12/2011
6	Cetuximab (Erbitux)FDA Link 12/2018 - 04/2006
6	Proteins (Proteins, Gene)FDA Link 03/2015 - 10/2005
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 06/2011
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 07/2015
5	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 04/2011
5	Phosphotransferases (Kinase)IBA 01/2019 - 01/2017
4	NivolumabIBA 01/2022 - 01/2018
3	Circulating Tumor DNAIBA 01/2020 - 01/2016
3	Leucovorin (Folinic Acid)FDA Link 01/2019 - 07/2014
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 04/2006
3	LipidsIBA 01/2018 - 11/2008
3	Pharmaceutical PreparationsIBA 10/2015 - 01/2013
3	Prednisone (Sone)FDA LinkGeneric 09/2015 - 11/2009
3	Biological ProductsIBA 02/2013 - 11/2005
3	ParaffinIBA 01/2013 - 11/2009
3	Messenger RNA (mRNA)IBA 01/2013 - 10/2002
2	pembrolizumabIBA 11/2022 - 10/2021
2	tyramine-deoxysorbitolIBA 02/2022 - 11/2021
2	Bevacizumab (Avastin)FDA Link 01/2022 - 10/2021
2	MicroRNAs (MicroRNA)IBA 11/2020 - 01/2013
2	cobimetinibIBA 01/2020 - 01/2018
2	PlatinumIBA 01/2019 - 01/2019
2	CytokinesIBA 12/2018 - 06/2013
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018 - 07/2016
2	Mitogen-Activated Protein KinasesIBA 01/2017 - 01/2010
2	AntibodiesIBA 01/2013 - 09/2010
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 08/2012 - 08/2004
2	Protein Isoforms (Isoforms)IBA 06/2011 - 08/2004
2	Vincristine (Oncovin)FDA LinkGeneric 05/2011 - 11/2009
2	Rituximab (Mabthera)FDA Link 05/2011 - 11/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2011 - 11/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2011 - 11/2009
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2008 - 06/2002
2	VaccinesIBA 07/2007 - 02/2007
2	TetraspaninsIBA 05/2006 - 07/2003
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2005 - 08/2004
1	IgKIBA 01/2022
1	XELOXIBA 01/2022
1	atezolizumabIBA 01/2022
1	Wnt1 ProteinIBA 03/2021
1	beta CateninIBA 03/2021
1	avelumabIBA 01/2021
1	NucleosidesIBA 12/2020
1	Cladribine FDA LinkGeneric 12/2020
1	trametinibIBA 01/2020
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2020
1	Bacterial DNAIBA 10/2019
1	CitrullineIBA 10/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2019
1	B7-H1 AntigenIBA 08/2019
1	Prion ProteinsIBA 08/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019

Therapy/Procedure

30	Therapeutics 01/2021 - 10/2005
11	Drug Therapy (Chemotherapy) 01/2021 - 11/2005
8	Adjuvant Chemotherapy 02/2022 - 12/2011
3	Liver Transplantation 05/2003 - 01/2002
2	Transplantation 01/2021 - 01/2008
2	Aftercare (After-Treatment) 02/2013 - 01/2008
1	Proctectomy 03/2022
1	Radiotherapy 01/2022
1	Endoscopes 11/2020
1	Lung Transplantation 01/2020
1	Off-Label Use 11/2019